Literature DB >> 26928669

Experimental Model System to Study pH Shift-Induced Aggregation of Monoclonal Antibodies Under Controlled Conditions.

Olubukayo-Opeyemi Oyetayo1, Hans Kiefer2.   

Abstract

PURPOSE: To present a convenient screening method for evaluating additive effects on the renaturation of an acid-exposed monoclonal antibody (mAb).
METHODS: The assay involves brief incubation of a mAb at acidic pH and subsequent neutralization in the absence or presence of additive to induce mainly aggregation. An increase in absorbance depicted aggregation. The recorded aggregation data traces were fitted with a nucleation-autocatalytic growth model for the extraction of kinetic parameters.
RESULTS: All kinetic data traces were fitted successfully with the selected model and the adjusted R square values were greater than 0.99. Trehalose had strongly stabilizing, proline mildly stabilizing and trimethylamine oxide had destabilizing effects on both the nucleation and growth phase of the reaction. Histidine was strongly stabilizing but was limited by its poor solubility.
CONCLUSION: The results demonstrate the suitability of the experimental mAb aggregation system and the nucleation-autocatalytic growth fit in the screening and quantification of additive effects on the renaturation of an acid-exposed mAb respectively. This will aid the investigation and derivation of quantitative structure-activity relationships of additive effects on mAb solubility.

Entities:  

Keywords:  aggregation kinetics; autocatalytic growth; monoclonal antibody; nucleation; refolding

Mesh:

Substances:

Year:  2016        PMID: 26928669     DOI: 10.1007/s11095-016-1878-4

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  38 in total

1.  Transient molten globules and metastable aggregates induced by brief exposure of a monoclonal IgG to low pH.

Authors:  Vasco Filipe; Başak Kükrer; Andrea Hawe; Wim Jiskoot
Journal:  J Pharm Sci       Date:  2012-04-19       Impact factor: 3.534

Review 2.  Recovery and purification process development for monoclonal antibody production.

Authors:  Hui F Liu; Junfen Ma; Charles Winter; Robert Bayer
Journal:  MAbs       Date:  2010-09-01       Impact factor: 5.857

3.  Nonnative aggregation of an IgG1 antibody in acidic conditions, part 2: nucleation and growth kinetics with competing growth mechanisms.

Authors:  Rebecca K Brummitt; Douglas P Nesta; Liuquan Chang; Andrew M Kroetsch; Christopher J Roberts
Journal:  J Pharm Sci       Date:  2011-01-06       Impact factor: 3.534

Review 4.  Advances in refolding of proteins produced in E. coli.

Authors:  H Lilie; E Schwarz; R Rudolph
Journal:  Curr Opin Biotechnol       Date:  1998-10       Impact factor: 9.740

5.  Conformational transitions and fibrillation mechanism of human calcitonin as studied by high-resolution solid-state 13C NMR.

Authors:  M Kamihira; A Naito; S Tuzi; A Y Nosaka; H Saitô
Journal:  Protein Sci       Date:  2000-05       Impact factor: 6.725

6.  Proline inhibits aggregation during protein refolding.

Authors:  D Samuel; T K Kumar; G Ganesh; G Jayaraman; P W Yang; M M Chang; V D Trivedi; S L Wang; K C Hwang; D K Chang; C Yu
Journal:  Protein Sci       Date:  2000-02       Impact factor: 6.725

7.  Molten globule intermediate of recombinant human growth hormone: stabilization with surfactants.

Authors:  N B Bam; J L Cleland; T W Randolph
Journal:  Biotechnol Prog       Date:  1996 Nov-Dec

8.  TMAO promotes fibrillization and microtubule assembly activity in the C-terminal repeat region of tau.

Authors:  Francesca Scaramozzino; Dylan W Peterson; Patrick Farmer; J T Gerig; Donald J Graves; John Lew
Journal:  Biochemistry       Date:  2006-03-21       Impact factor: 3.162

Review 9.  Fitting neurological protein aggregation kinetic data via a 2-step, minimal/"Ockham's razor" model: the Finke-Watzky mechanism of nucleation followed by autocatalytic surface growth.

Authors:  Aimee M Morris; Murielle A Watzky; Jeffrey N Agar; Richard G Finke
Journal:  Biochemistry       Date:  2008-02-05       Impact factor: 3.162

10.  In vitro amyloid aggregate forming ability of TGFBI mutants that cause corneal dystrophies.

Authors:  Gary Hin-Fai Yam; Kaijie Wang; Vishal Jhanji; Kwong-Wai Choy; Larry Baum; Chi-Pui Pang
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-08-27       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.